Plasma Cell Dyscrasias
Plasma Cell Dyscrasias
Explore linked clinical trials. Standard reference: MESH:M04082543 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource | Blood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, Plasma Cell Dyscrasias, amyloidosis, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, monoclonal gammopathy of uncertain significance, neoplasm, plasma cell neoplasm, proteostasis deficiencies, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2026-03-23 | NCT01408225 | |
| Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell Disorders | Blood Protein Disorders, Hemic and Lymphatic Diseases, Plasma Cell Dyscrasias, hematologic disorder, immune system disorder, immunoproliferative disorder, monoclonal gammopathy | Not yet recruiting | Early phase 1 | 2026-01-26 | NCT07365059 | |
| The Indiana Myeloma Registry | Blood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, Neoplasms by Histologic Type, Plasma Cell Dyscrasias, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, monoclonal gammopathy of uncertain significance, neoplasm, plasma cell neoplasm, plasmacytoma, precancerous condition, smoldering plasma cell myeloma, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2025-11-10 | NCT03616483 |